LEADOPTIK Patents

Patent portfolio assigned to LEADOPTIK (verified via public assignee records). Estimated patent count: 3. Metamaterial-optics ultra-thin imaging probe for early lung cancer / minimally invasive interventions, San Jose CA. Patents confirmed: US11953698B1 plus PCT-based grants in Europe and Japan (3 key patents across 3 continents per PR Newswire). No named customers (pre-commercial). Competitors from CB Insights.